Uveitis Treatment Market is likely to expand at a stable CAGR of 6.5% During 2016-2024

Digital Daily NewsRead the rest “Uveitis Treatment Market is likely to expand at a stable CAGR of 6.5% During 2016-2024”

BlueWater Angels among state’s most enviable investors

Crain’s Detroit BusinessRead the rest “BlueWater Angels among state’s most enviable investors”

Allergan prepares to expand Waco facility after delays

Waco Tribune-HeraldRead the rest “Allergan prepares to expand Waco facility after delays”

Tech Coast Angels Invested $14.1 Million into 55 Companies and Completed Six Exits in 2016

For PR Web, click here

During its 20th Year, Angel Network also Launched Angel Syndication Network to Share Deals with over 20 Other Angel Groups 

IRVINE, Calif. – April 25, 2017 – Tech Coast Angels (TCA) invested $14.1 million in a total of 55 companies in a diverse mix of industries in 2016.… Read the rest “Tech Coast Angels Invested $14.1 Million into 55 Companies and Completed Six Exits in 2016”

Retrosense Therapeutics: Looking beyond Traverse City’s tourism: Northern Michigan angel fund aims to broaden economic base, create year-round jobs

Crain’s Detroit BusinessRead the rest “Retrosense Therapeutics: Looking beyond Traverse City’s tourism: Northern Michigan angel fund aims to broaden economic base, create year-round jobs”

Retrosense Therapeutics: Life sciences sector is heartbeat of Michigan innovation

click hereRead the rest “Retrosense Therapeutics: Life sciences sector is heartbeat of Michigan innovation”

Retrosense Therapeutics: Tech innovators honored at Michigan Venture Capital Association awards dinner

click hereRead the rest “Retrosense Therapeutics: Tech innovators honored at Michigan Venture Capital Association awards dinner”

Retrosense Therapeutics: What Allergan Is Buying and Shedding to Gain a Better Position

click hereRead the rest “Retrosense Therapeutics: What Allergan Is Buying and Shedding to Gain a Better Position”

RetroSense to be honored at TechTown awards program for $60 million sale

click hereRead the rest “RetroSense to be honored at TechTown awards program for $60 million sale”

The RetroSense Story: A Life Science Journey to Success

click hereRead the rest “The RetroSense Story: A Life Science Journey to Success”

Retrosense Therapeutics: WSU research leads to algae treatment for blindness

click hereRead the rest “Retrosense Therapeutics: WSU research leads to algae treatment for blindness”

With small RetroSense deal, Allergan hoping for big win

click hereRead the rest “With small RetroSense deal, Allergan hoping for big win”

Allergan seizes visionary Optogenetic Therapy from US Startup Retrosense Therapeutics

click hereRead the rest “Allergan seizes visionary Optogenetic Therapy from US Startup Retrosense Therapeutics”

Allergan buys gene therapy company, RetroSense Therapeutics

click hereRead the rest “Allergan buys gene therapy company, RetroSense Therapeutics”

Allergan acquires RetroSense Therapeutics

click hereRead the rest “Allergan acquires RetroSense Therapeutics”

Allergan Acquires RetroSense Therapeutics

click hereRead the rest “Allergan Acquires RetroSense Therapeutics”

Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline

click hereRead the rest “Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline”

BRIEF-Allergan acquires gene therapy company Retrosense Therapeutics

click hereRead the rest “BRIEF-Allergan acquires gene therapy company Retrosense Therapeutics”

Allergan (AGN) Acquires RetroSense Therapeutics

click hereRead the rest “Allergan (AGN) Acquires RetroSense Therapeutics”

Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline

click hereRead the rest “Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline”

Allergan snaps up gene therapy startup Retrosense Therapeutics to restore vision in rare disease patients

click hereRead the rest “Allergan snaps up gene therapy startup Retrosense Therapeutics to restore vision in rare disease patients”

RetroSense Therapeutics Secures Exclusive Worldwide Rights to ReaChR Optogene from the University of California San Diego

click hereRead the rest “RetroSense Therapeutics Secures Exclusive Worldwide Rights to ReaChR Optogene from the University of California San Diego”

RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics

click hereRead the rest “RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics”

RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics

click hereRead the rest “RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics”

RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics

click hereRead the rest “RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics”

RetroSense Therapeutics has been named one of the nation’s 50 smartest companies by the MIT Technology Review

click hereRead the rest “RetroSense Therapeutics has been named one of the nation’s 50 smartest companies by the MIT Technology Review”

RetroSense Therapeutics Tech magazine ranks Wayne State spinoff as 37th smartest company in world

click hereRead the rest “RetroSense Therapeutics Tech magazine ranks Wayne State spinoff as 37th smartest company in world”

RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016

click hereRead the rest “RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016”

RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016

click hereRead the rest “RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016”

RetroSense Therapeutics Selected as a Red Herring Top 100 North America Winner

click hereRead the rest “RetroSense Therapeutics Selected as a Red Herring Top 100 North America Winner”

Light-controlled genes and neurons poised for clinical trials

click hereRead the rest “Light-controlled genes and neurons poised for clinical trials”

RetroSense Therapeutics to Highlight Contributions to Gene Therapy Research in Upcoming Conferences

click hereRead the rest “RetroSense Therapeutics to Highlight Contributions to Gene Therapy Research in Upcoming Conferences”

Tech Coast Angels Invested Best Ever $16.37 Million in 2014

Southern California Angel Network Surpasses Previous Records for Both Investments and Activity

IRVINE, Calif. January 29, 2015 Tech Coast Angels (TCA) invested a total of $16,373,337 in 61 total deals in Calendar Year 2014. The angel network announced that 2014 was the most active year since the networks inception in 1997 for number of deals funded, and capital raised was also the largest ever.… Read the rest “Tech Coast Angels Invested Best Ever $16.37 Million in 2014”